News
LGBTQ patients face unique skin risks
Watch out for skin cancer in gay men, hormone-induced acne in transmasculine patients
News
Psoriasis associated with an increased risk of COVID-19 in real-world study
Those treated with TNF-alpha inhibitors, methotrexate, and apremilast had statistically lower risks of COVID-19 vs. those on topical therapy.
News
Tofacitinib: Small study shows big cutaneous sarcoidosis response
“Not only did patients get better, but they were in many cases able to come off their baseline immunosuppressive regimen."
News
S1P-receptor modulator shows promise in phase 2b AD trial
Experimental medication appears to prevent immune cells from entering the skin, study presenter says.
News
What will neurology look like post pandemic?
Neurologists expect telemedicine – and post–COVID-19 sequelae – to stick around.
News
Can supplementary estrogen relieve MS symptoms in menopausal women?
Research suggests lowered hormone levels may worsen the disease.
News
Infantile hemangiomas: Accurate diagnosis is crucial
Consider propranolol a “life changer” in extreme cases.
News
Managing hyperhidrosis, HS: Ask questions first
Ask the patient a simple question: “What bothers you the most?”
News
Disease progression and therapy response vary in MS by ethnicity
African Americans and Hispanics had more severe illness than Caucasians, and there were other differences as well.
News
Newly approved drugs offer new hope in NMOSD
Trio of medications offer relief from relapses, neurologist tells colleagues
News
Infections – especially urinary and kidney – are higher in MS
Among patients with MS, the infection rate was more than quadruple the rate in a control cohort.
News
Anti-CD20s linked to higher COVID-19 severity in MS
Older age and disability are also linked to extra risk, registries find, but not other DMTs.
News
Certain DMTs in MS may attenuate COVID-19 vaccines
Adjust timing if feasible, neurologist says, but focus on getting shots in arms.
News
COVID-19: Another study links colchicine to better results
Brazilian trial tested gout drug against placebo in hospitalized patients.